PTX 2.13% 4.6¢ prescient therapeutics limited

https://www.biopharmadive.com/news/janux-t-cell-engager-cancer-dr...

  1. 92 Posts.
    lightbulb Created with Sketch. 59
    https://www.biopharmadive.com/news/janux-t-cell-engager-cancer-drug-data-shares/708621/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue:%202024-02-27%20BioPharma%20Dive%20%5Bissue:59531%5D&utm_term=BioPharma%20Dive

    Currently just released Phase 1 study result valuations have reached USD $2.3billion. Omnicar might be early stage but wont need to get deep into clinical trials to attract high valuations like we have seen done by multiple companies in the space we just need data to correlate investor sentiment. XBI has just broken out PTX RSI is oversold FDA meeting around the corner.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.6¢
Change
-0.001(2.13%)
Mkt cap ! $37.04M
Open High Low Value Volume
4.7¢ 4.7¢ 4.6¢ $3.926K 84.64K

Buyers (Bids)

No. Vol. Price($)
3 214412 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.6¢ 59748 2
View Market Depth
Last trade - 10.25am 05/06/2024 (20 minute delay) ?
Last
4.6¢
  Change
-0.001 ( 0.00 %)
Open High Low Volume
4.6¢ 4.6¢ 4.5¢ 185915
Last updated 12.29pm 05/06/2024 ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.